[DPHARMA] YoY TTM Result on 30-Sep-2015 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- -0.14%
YoY- 2.05%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Revenue 495,341 429,767 328,308 232,663 171,671 152,048 132,969 24.49%
PBT 54,833 45,270 42,709 46,157 41,729 40,017 34,133 8.21%
Tax -9,793 -5,416 -9,379 -8,786 -7,856 -9,845 -7,787 3.89%
NP 45,040 39,854 33,330 37,371 33,873 30,172 26,346 9.34%
-
NP to SH 45,277 40,548 34,022 34,569 33,873 30,172 26,346 9.43%
-
Tax Rate 17.86% 11.96% 21.96% 19.04% 18.83% 24.60% 22.81% -
Total Cost 450,301 389,913 294,978 195,292 137,798 121,876 106,623 27.12%
-
Net Worth 501,487 474,230 451,913 268,530 187,531 179,017 167,991 19.98%
Dividend
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Div 20,937 7,085 8,084 25,710 24,291 20,128 18,318 2.25%
Div Payout % 46.24% 17.47% 23.76% 74.38% 71.71% 66.71% 69.53% -
Equity
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Net Worth 501,487 474,230 451,913 268,530 187,531 179,017 167,991 19.98%
NOSH 661,881 278,959 278,959 278,959 138,912 138,773 138,836 29.71%
Ratio Analysis
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
NP Margin 9.09% 9.27% 10.15% 16.06% 19.73% 19.84% 19.81% -
ROE 9.03% 8.55% 7.53% 12.87% 18.06% 16.85% 15.68% -
Per Share
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
RPS 75.07 154.06 117.69 139.50 123.58 109.57 95.77 -3.97%
EPS 6.86 14.54 12.20 20.73 24.38 21.74 18.98 -15.59%
DPS 3.17 2.54 2.90 15.42 17.50 14.50 13.20 -21.15%
NAPS 0.76 1.70 1.62 1.61 1.35 1.29 1.21 -7.45%
Adjusted Per Share Value based on latest NOSH - 278,959
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
RPS 51.49 44.68 34.13 24.19 17.85 15.81 13.82 24.49%
EPS 4.71 4.22 3.54 3.59 3.52 3.14 2.74 9.44%
DPS 2.18 0.74 0.84 2.67 2.53 2.09 1.90 2.31%
NAPS 0.5213 0.493 0.4698 0.2792 0.195 0.1861 0.1746 19.98%
Price Multiplier on Financial Quarter End Date
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Date 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 -
Price 1.23 2.20 2.06 2.72 3.17 2.55 2.36 -
P/RPS 1.64 1.43 1.75 1.95 2.57 2.33 2.46 -6.53%
P/EPS 17.93 15.14 16.89 13.12 13.00 11.73 12.44 6.27%
EY 5.58 6.61 5.92 7.62 7.69 8.53 8.04 -5.90%
DY 2.58 1.15 1.41 5.67 5.52 5.69 5.59 -12.08%
P/NAPS 1.62 1.29 1.27 1.69 2.35 1.98 1.95 -3.04%
Price Multiplier on Announcement Date
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Date 28/11/18 17/11/17 21/11/16 24/11/15 21/11/14 19/11/13 23/11/12 -
Price 1.07 2.20 2.10 2.70 3.01 2.56 2.28 -
P/RPS 1.43 1.43 1.78 1.94 2.44 2.34 2.38 -8.13%
P/EPS 15.59 15.14 17.22 13.03 12.34 11.77 12.01 4.44%
EY 6.41 6.61 5.81 7.68 8.10 8.49 8.32 -4.25%
DY 2.97 1.15 1.38 5.71 5.81 5.66 5.79 -10.52%
P/NAPS 1.41 1.29 1.30 1.68 2.23 1.98 1.88 -4.67%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment